91 related articles for article (PubMed ID: 8959283)
1. A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.
Knable MB; Hyde TM; Murray AM; Herman MM; Kleinman JE
Biol Psychiatry; 1996 Dec; 40(12):1191-9. PubMed ID: 8959283
[TBL] [Abstract][Full Text] [Related]
2. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
[TBL] [Abstract][Full Text] [Related]
3. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
4. Locomotor activity and a conditioned fear response: correlation with cortical and subcortical binding of the dopamine D1 receptor antagonist.
Siemiatkowski M; Rokicki D; Członkowska AI; Sienkiewicz-Jarosz H; Bidziński A; Płaźnik A
Neuroreport; 2000 Dec; 11(18):3953-6. PubMed ID: 11192608
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain.
Benes FM; Todtenkopf MS; Taylor JB
Synapse; 1997 Jan; 25(1):80-92. PubMed ID: 8987151
[TBL] [Abstract][Full Text] [Related]
6. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
7. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
Hernandez I; Sokolov BP
J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
[TBL] [Abstract][Full Text] [Related]
9. An increase in [3H]SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics.
Domyo T; Kurumaji A; Toru M
J Neural Transm (Vienna); 2001; 108(12):1475-84. PubMed ID: 11810409
[TBL] [Abstract][Full Text] [Related]
10. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice.
Stanwood GD; Parlaman JP; Levitt P
J Comp Neurol; 2005 Jul; 487(3):270-82. PubMed ID: 15892099
[TBL] [Abstract][Full Text] [Related]
11. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
Knable MB; Hyde TM; Herman MM; Carter JM; Bigelow L; Kleinman JE
Biol Psychiatry; 1994 Dec; 36(12):827-35. PubMed ID: 7893846
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
13. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Karlsson P; Farde L; Halldin C; Sedvall G
Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.
Dolan RJ; Fletcher P; Frith CD; Friston KJ; Frackowiak RS; Grasby PM
Nature; 1995 Nov; 378(6553):180-2. PubMed ID: 7477319
[TBL] [Abstract][Full Text] [Related]
16. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
Yasuno F; Suhara T; Okubo Y; Ichimiya T; Takano A; Sudo Y; Inoue M
Psychiatry Res; 2005 Apr; 138(3):197-207. PubMed ID: 15854788
[TBL] [Abstract][Full Text] [Related]
17. Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study.
Wedzony K; Chocyk A; Maćkowiak M; Fijał K; Czyrak A
J Physiol Pharmacol; 2000 Jun; 51(2):205-21. PubMed ID: 10898094
[TBL] [Abstract][Full Text] [Related]
18. Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia.
Noga JT; Wang H
Synapse; 2002 Sep; 45(4):250-8. PubMed ID: 12125046
[TBL] [Abstract][Full Text] [Related]
19. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
